Atrial fibrillation: Difference between revisions
No edit summary |
Varun Kumar (talk | contribs) m (→Treatment) |
||
| Line 31: | Line 31: | ||
==Treatment== | ==Treatment== | ||
[[Atrial fibrillation urgent treatment|Urgent treatment]] | ===[[Atrial fibrillation urgent treatment|Urgent treatment]]=== | ||
[[Atrial fibrillation overview of treatment|Overview and General Treatment Strategies]] | ===[[Atrial fibrillation overview of treatment|Overview and General Treatment Strategies]]=== | ||
===Anticoagulation=== | ===Anticoagulation=== | ||
[[Atrial fibrillation anticoagulation]] | [[Atrial fibrillation anticoagulation]] | [[Warfarin]] | [[Dabigatran]] | ||
[[Warfarin]] | |||
[[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]] | |||
'''[[Dabigatran]]:''' [[dabigatran#Dosing|Dosing]] | [[Dabigatran#Surgery and Interventions|Discontinuation for Surgery and Interventions]] | [[Dabigatran#WARNINGS AND PRECAUTIONS| Warnings and Precautions]] | [[Dabigatran#Adverse Reactions|Adverse Reactions]] | [[Dabigatran#Use in Specific Populations|Use in Specific Populations Such as Pregnancy]] | [[Dabigatran#Overdosage|Overdosage]] | [[Clinical Pharmacology of Dabigatran|Clinical Pharmacology]] | [[FDA Review of Data From the RE-LY Trial on September 20th, 2010|FDA Review of the RE-LY Data]] | [[A comparison of the RE-LY and Rocket AF Trials ]] | [[Estimates of Cost Per Year of Life Saved for Dabigatran]] | |||
===Rate Control=== | ===Rate Control=== | ||
Revision as of 15:43, 29 October 2011
| Atrial fibrillation | |
| ICD-10 | I48 |
|---|---|
| ICD-9 | 427.31 |
| DiseasesDB | 1065 |
| MedlinePlus | 000184 |
|
Atrial Fibrillation Microchapters | |
|
Special Groups | |
|---|---|
|
Diagnosis | |
|
Treatment | |
|
Cardioversion | |
|
Anticoagulation | |
|
Surgery | |
|
Case Studies | |
|
Atrial fibrillation On the Web | |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and related keywords: AF, Afib, fib, PAF, paroxysmal afib, Lone fibrillator
Overview
Pathophysiology
Epidemiology and demographics
Risk Factors
Diagnosis
Symptoms | Screening | Physical Examination | Laboratory Tests | Electrocardiogram | Chest X ray | Echocardiography | Holter monitoring | Exercise stress testing
Treatment
Urgent treatment
Overview and General Treatment Strategies
Anticoagulation
Atrial fibrillation anticoagulation | Warfarin | Dabigatran
Converting from or to Warfarin | Converting from or to Parenteral Anticoagulants
Dabigatran: Dosing | Discontinuation for Surgery and Interventions | Warnings and Precautions | Adverse Reactions | Use in Specific Populations Such as Pregnancy | Overdosage | Clinical Pharmacology | FDA Review of the RE-LY Data | A comparison of the RE-LY and Rocket AF Trials | Estimates of Cost Per Year of Life Saved for Dabigatran
Rate Control
Maintenance of Sinus Rhythm | Rate Control | Cardioversion | Invasive Treatment | Surgical Treatment
Special Considerations
Postoperative AF | Acute Myocardial Infarction | Wolff-Parkinson-White Preexcitation Syndromes | Hyperthyroidism | Pregnancy | Hypertrophic Cardiomyopathy | Pulmonary Diseases
Follow-Up and Secondary Prevention
Overview
Clinical Trial Data
Overview
Guidelines: Diagnosis and Management of Atrial Fibrillation
External links
- American Heart Association's page on atrial fibrillation
- Atrial fibrillation
- Bandolier: Evidence-based medicine resource on atrial fibrillation
See also
References
Further Readings
- Fuster V, Rydén LE, Cannom DS, et al (2006). "ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society". Circulation 114 (7): e257-354. doi:10.1161/CIRCULATIONAHA.106.177292. PMID 16908781.
- Estes NAM 3rd, Halperin JL, Calkins H, Ezekowitz MD, Gitman P, Go AS, McNamara RL, Messer JV, Ritchie JL, Romeo SJW, Waldo AL, Wyse DG. ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with non valvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Performance Measures for Atrial Fibrillation). Circulation 2008; 117:1101–1120
de:Vorhofflimmern it:Fibrillazione atriale nl:Boezemfibrilleren no:Atrieflimmer fi:Eteisvärinä